Free Trial
NYSE:DGX

Quest Diagnostics Q2 2025 Earnings Report

Quest Diagnostics logo
$179.74 +0.31 (+0.17%)
Closing price 06/23/2025 03:59 PM Eastern
Extended Trading
$179.90 +0.16 (+0.09%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quest Diagnostics EPS Results

Actual EPS
N/A
Consensus EPS
$2.56
Beat/Miss
N/A
One Year Ago EPS
N/A

Quest Diagnostics Revenue Results

Actual Revenue
N/A
Expected Revenue
$2.73 billion
Beat/Miss
N/A
YoY Revenue Growth
N/A

Quest Diagnostics Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Tuesday, July 22, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Quest Diagnostics Earnings Headlines

Buffett’s $325 Billion Cash Problem — Solved by Gold?
A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.
Is Quest Diagnostics Stock Outperforming the Nasdaq?
See More Quest Diagnostics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Quest Diagnostics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quest Diagnostics and other key companies, straight to your email.

About Quest Diagnostics

Quest Diagnostics (NYSE:DGX) provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

View Quest Diagnostics Profile

More Earnings Resources from MarketBeat